AXIOS September 11, 2023
Jason Millman

The Food and Drug Administration approved updated versions of COVID-19 vaccines on Monday, a key step in getting the new shots to Americans as early as this week.

Why it matters: The Biden administration has faced increasing calls to make the reformulated vaccines available more quickly as infections and hospitalizations ticked up in recent weeks.

  • Health officials have largely urged people concerned about protecting themselves against the late-summer surge to wait until the new boosters are available.

Driving the news: The FDA greenlit shots from Pfizer and Moderna that are targeted against the XBB.1.5 variant, which was the dominant strain circulating in the United States earlier this summer.

  • Scientists believe that the shots will be protective against...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
Related Articles:
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee

Share This Article